[1]黄芊,张扶莉,李雪莲,等.阳和汤对人乳腺癌MDA-MB-231细胞增殖、凋亡及其Akt/mTOR信号通路的影响*[J].陕西中医,2018,(11):1497-1500.
 Huang Qian,Zhang Fuli,Li Xuelian,et al.Effect of Yanghe decoction on proliferation, apoptosis and Akt/mTOR signaling pathway in human breast cancer MDA-MB-231 cells[J].,2018,(11):1497-1500.
点击复制

阳和汤对人乳腺癌MDA-MB-231细胞增殖、凋亡及其Akt/mTOR信号通路的影响*
分享到:

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2018年11期
页码:
1497-1500
栏目:
基础研究
出版日期:
2018-12-31

文章信息/Info

Title:
Effect of Yanghe decoction on proliferation, apoptosis and Akt/mTOR signaling pathway in human breast cancer MDA-MB-231 cells
文章编号:
10.3969/j.issn.1000-7369.2018.11.002
作者:
黄芊1张扶莉1李雪莲1尚荣国2许崇文3钱建升3窦建卫2
1.西安市中医医院(西安 710021),2.西安交通大学医学部(西安 710061),3.西安交通大学第一附属医院 (西安 710061)
Author(s):
Huang Qian Zhang Fuli Li Xuelian et al.
Xi’an Traditional Chinese Medicine Hospital(Xi’an 710021)
关键词:
乳腺肿瘤/中医药疗法阳和汤/治疗应用动物实验大鼠
Keywords:
Breast neoplasms/traditionalChinese medicine therapyYang He Tang/therapeutic usesAnimal experimentationRats
分类号:
R737.9
文献标志码:
A
摘要:
目的:通过阳和汤大鼠含药血清干预MDA-MB-231细胞,探索阳和汤对MDA-MB-231细胞增殖、凋亡及其Akt/mTOR信号通路的影响。 方法:阳和汤含药血清(或阳性药)干预MDA-MB-231细胞24、48、72 h后,CCK-8法检测细胞OD值,计算细胞抑制率。阳和汤含药血清(或阳性药)干预MDA-MB-231细胞24 h后,流式细胞术检测细胞凋亡;Western blot检测细胞Akt/mTOR信号通路蛋白的表达。 结果:干预24、48、72 h后,与空白对照组相比,阳和汤低、高剂量组和阳性药物组细胞抑制率分别均增高(P<0.01)。干预24 h后,与空白对照组相比,阳和汤低、高剂量组和阳性药物组细胞凋亡率均增高(P<0.01);Bcl-2/Bax值均降低(P<0.05或0.01)。干预24 h后,与空白对照组相比,阳和汤低、高剂量组和阳性药物组mTOR磷酸化率、Akt磷酸化率均降低(P<0.05或0.01)。 结论:阳和汤治疗乳腺癌的作用机制可能是通过抑制Akt/mTOR信号通路的活化,从而抑制乳腺癌细胞的增殖、诱导其凋亡,发挥抗癌作用。
Abstract:
Objective: MDA-MB-231 cells were intervened by Yanghe decoction medicated serum to explore the effects of Yanghe decoction on proliferation, apoptosis and Akt/mTOR signaling pathway. Methods: Medicated serum (or positive drug) was used to intervene MDA-MB-231 cells for 24 h, 48 h, and 72 h, and the cell OD value was determined by CCK-8 method to calculate inhibition rate. Apoptosis was detected by flow cytometry and the levels of Akt/mTOR signaling pathway proteins were detected by western blot after intervened by medicated serum (or positive drug) for 24 h. Results: After 24, 48, and 72 h of intervention, the inhibition rate of low dose group, high dose group and positive drug group increased (P<0.01). After intervention of 24 h, the apoptosis rate of low dose group, high dose group and positive drug group increased, Bcl-2/Bax value decreased, and mTOR and Akt phosphorylation rate of the low dose group, high dose group and positive drug group decreased (P<0.05 or 0.01). Conclusions: The effects of Yanghe decoction on breast cancer maybe inhibit Akt/mTOR signaling pathway to suppress proliferation of breast cancer cells and induce apoptosis.

参考文献/References:

[1]于加军,邰阳升.安宫牛黄丸联合亚低温治疗脑出血并发中枢性高热的疗效观察[J].中医临床研究,2015,7(7):17-19.
[2]杜宝坤,孙艳云.安宫牛黄丸治疗急性中风效果分析[J].中国实用医药,2016,11(4):182-184.
[3]马丽虹,田财军,师冉.丹红注射液治疗出血性中风急性期临床疗效的系统评价[J].中国中医急症,2012,21(12):1960-1962.
[4]曾春桂.活血化瘀中药治疗出血性中风急性期的分析[J].湖北中医杂志,2013,35(8):29-31.
[5]贺艳霞.综合性康复训练对脑卒中患者神经功能恢复的影响[J].陕西医学杂志,2013,6(5):74-76.
[6]谢祖艺,陈碧霞.醒脑开窍针刺联合安宫牛黄丸治疗中风昏迷随机平行对照研究[J].实用中医内科杂志,2017,31(8):61-63.
[7]中华医学会第四届全国脑血管病学术会议.脑卒中患者临床神经功能缺损程度评分标准及临床疗效评定标准[J].中华神经科杂志,1996,29(6):381-383.
[8]冯跃明,杨辉.安宫牛黄丸治疗急性脑梗死昏迷患者促醒作用的观察[J].中国实验方剂学杂志,2015,29(6):179-182.
[9]郑涛,杨淑焕.补阳还五汤加减治疗中风病恢复期41例[J].陕西中医,2015,36(5):546-548.
[10]崔闫,陈祖君,杜鹃,等.安宫牛黄丸对冠状动脉搭桥术后中风(阳闭证)患者的影响[J].中国中西医结合杂志,2016,19(4):492-493.
[11]李永清.中医药治疗出血性中风急性期临床观察[J].中国实用神经疾病杂志,2012,15(7):61-62.
[12]刘建浩,鲍春龄,朱文增,等.针刺头穴治疗中风病偏瘫时发生即刻效应的临床观察[J].中医学报,2013,28(8):1259-1260.
[13]聂志玲,张腾.活血化瘀法在出血性中风急性期之应用[J].中国中医急症,2012,21(9):1449-1450.
[14]李求兵,李冬梅,李可建.安宫牛黄丸治疗老年重症急性脑血管疾病疗效观察[J].中西医结合心脑血管病杂志,2013,11(4):402-403.

备注/Memo

备注/Memo:
*国家自然科学基金资助项目(81573983, 81873311) 陕西省重点研发计划项目(2017SF-109)
更新日期/Last Update: 2018-11-30